SLSN
SLSN
NASDAQ · Chemicals

Solesence Inc

$1.21
-0.10 (-7.63%)
As of May 16, 9:41 PM ET ·
Financial Highlights (FY 2026)
Revenue
61.81M
Net Income
1.79M
Gross Margin
25.9%
Profit Margin
2.9%
Rev Growth
+18.5%
D/E Ratio
0.87
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 25.9% 25.9% 44.0% 44.0%
Operating Margin 2.5% 2.3% 20.4% 16.3%
Profit Margin 2.9% 2.7% 13.0% 15.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 61.81M 52.17M 30.11M 28.35M
Gross Profit 16.00M 13.50M 13.23M 12.46M
Operating Income 1.56M 1.19M 6.14M 4.63M
Net Income 1.79M 1.36M 3.91M 4.44M
Gross Margin 25.9% 25.9% 44.0% 44.0%
Operating Margin 2.5% 2.3% 20.4% 16.3%
Profit Margin 2.9% 2.7% 13.0% 15.7%
Rev Growth +18.5% +18.5% +8.3% +13.0%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 21.47M 21.47M 14.89M 14.06M
Total Equity 24.80M 24.80M 59.27M 54.81M
D/E Ratio 0.87 0.87 0.25 0.26
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 3.68M 2.95M 7.35M 6.83M
Free Cash Flow 3.76M 3.68M